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Abstract
Objective: To study the effects of reduced lighting on the gait of older adults with a high level gait
disorder (HLGD) and to compare their response to that of healthy elderly controls.
Methods: 22 patients with a HLGD and 20 age-matched healthy controls were studied under usual
lighting conditions (1000 lumens) and in near darkness (5 lumens). Gait speed and gait dynamics
were measured under both conditions. Cognitive function, co-morbidities, depressive symptoms,
and vision were also evaluated.
Results: Under usual lighting conditions, patients walked more slowly, with reduced swing times,
and increased stride-to-stride variability, compared to controls. When walking under near
darkness conditions, both groups slowed their gait. All other measures of gait were not affected by
lighting in the controls. In contrast, patients further reduced their swing times and increased their
stride-to-stride variability, both stride time variability and swing time variability. The unique
response of the patients was not explained by vision, mental status, co-morbidities, or the values
of walking under usual lighting conditions.
Conclusion: Walking with reduced lighting does not affect the gait of healthy elderly subjects,
except for a reduction in speed. On the other hand, the gait of older adults with a HLGD becomes
more variable and unsteady when they walk in near darkness, despite adapting a slow and cautious
gait. Further work is needed to identify the causes of the maladaptive response among patients with
a HLGD and the potential connection between this behavior and the increased fall risk observed
in these patients.
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Introduction
Many older adults have an impaired gait that does not
appear to be a result of any well defined disease [1]. In
their review of patients attending a neurology clinic,
Sudarsky et al. reported that the cause of the gait distur-
bance was unknown, even after neuro-imaging, in about
10–20 percent of older adults with a disturbed gait [2,3].
In a study of the "oldest old" (age range 87 to 97 years) in
the Netherlands, Bloem et al. observed that about 20 per-
cent of those studied had a normal gait, 69 percent had a
gait disorder due to known disease, and about 11 percent
of the subjects had an idiopathic "senile gait disorder",
i.e., a gait disorder of unknown origin [4]. Of note, those
subjects with a gait disorder of unknown origin had a
higher risk of mortality during a five year follow up
period, compared to the group of age-matched subjects
who had a normal gait [5], suggesting that the origin of
this gait disorder is not benign.
Nutt et al. coined the term "higher-level" gait disorders
(HLGD) to refer to an altered gait that is not a result of
lower extremity or peripheral dysfunction and cannot be
attributed to well defined chronic disease [6,7]. One com-
mon example of a HLGD is the idiopathic "cautious" gait
of the elderly or the "senile gait" disorder [6,7]. A "cau-
tious" gait is typically marked by mild to moderate slow-
ing, reduced stride length, and mild widening of the base
of support [7]. Previous studies have shown that older
adults with a cautious gait and HLGD also walk with
increased stride variability and unsteadiness, have an
excessive fear of falling that appears to be related to this
increased stride variability, and have an increased risk of
falls [8,9]. Further, the extrapyramidal, limbic systems,
and the frontal lobe apparently play an important role, to
different degrees, in what can be viewed as a multi-system
neurodegenerative syndrome clearly different from
"aging" [8]. Indeed, a three year prospective study found
that gait and function deteriorated to a much greater
extent among older adults with a HLGD, compared to
controls, supporting the idea that this is a progressive neu-
rodegenerative disorder [10]. However, the origin of the
cautious gait in older adults with a HLGD remains largely
unknown.
The gait changes observed in patients with a HLGD have
features common to subjects who walk in the dark or with
impaired vision, i.e., to others who might be walking cau-
tiously. When vision is altered or lighting is reduced, sub-
jects typically adapt a slower gait [11-13]. Variability of
foot placement, at least during gait termination, may also
be increased when lighting is not adequate [12]. These
changes are reminiscent of the walking pattern of older
adults with a HLGD and cautious gait. An elevated risk of
falling has been associated with visual impairments, a
problem that increases with age [14-17] and fall risk has
also been associated with inadequate lighting, but the
effects of vision and lighting have not been studied in
older adults with a HLGD. To more fully characterize the
gait of older adults with a HLGD and their reliance on vis-
ual input, we examined the effect of lighting changes on
the gait of older adults with a HLGD and compared their
response to that of healthy elderly controls. More specifi-
cally, we hypothesized that the response to near darkness
may exacerbate gait instability and fall risk markers in
these patients.
Methods
Participants
Twenty-two older adults between the ages of 70 and 90
years old who met previously established criteria for a
HLGD [8,9] were included in the present study. Patients
were recruited from among those who came to the Geriat-
ric Outpatient Clinic or the Movement Disorders Unit at
the Tel Aviv Sourasky Medical Center for evaluation of
walking difficulties of unknown origin. All patients were
mobile and walked independently at the time of assess-
ment and all underwent a thorough general and neurolog-
ical examination to ensure that subjects met the criteria of
HLGD.
Patients were excluded if the cause of their gait distur-
bance could be readily established. Thus, patients with a
history of clinically established stroke, Parkinson's dis-
ease, Alzheimer's disease, possible normal pressure
hydrocephalus or other diagnosed neurodegenerative dis-
order, and patients with rest tremor or pronounced brady-
kinesia were excluded. Patients who were taking anti-
parkinsonian or anti-spastic medications, or had orthos-
tatic hypotension were also excluded. We also excluded
patients with significant visual, peripheral, or vestibular
disturbances, as well as patients with significant ortho-
pedic disturbances. Patients with dementia according to
the DSM IV criteria [18], history of psychiatric disease, or
past use of dopamine receptor blocking agents (anti-psy-
chotic medications) were excluded as well. In addition,
we excluded patients with a history of traumatic head
injury and/or loss of consciousness. In brief, no specific
disorder could be diagnosed as the cause of the patients'
complaint about his or her walking difficulties.
The patient population was compared to a group of
twenty healthy controls of similar age. Control subjects
were recruited from the community and from nearby eld-
erly housing facilities or were spouses of outpatients. Sub-
jects were included if they were between 70 and 90 years
of age, reported normal walking function, had no obvious
clinical impairment, and did not have significant cogni-
tive impairment (Mini Mental State Examination >25
[19]). Subjects were excluded if they had any neurologicalJournal of NeuroEngineering and Rehabilitation 2005, 2:27 http://www.jneuroengrehab.com/content/2/1/27
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disorder or any significant clinical history likely to affect
their gait (e.g., stroke).
The study was approved by the Human Studies committee
of the Tel-Aviv Sourasky Medical Center. All subjects pro-
vided informed written consent according to the declara-
tion of Helsinki prior to entering the study.
Subject Characteristics and Assessment of Vision
The Mini Mental State Examination (MMSE) [19] and the
Geriatric Depression Scale (GDS) [20] were administered
to probe the mental health of the subjects. Body-mass-
index (BMI) was determined and Charlson's co-morbidity
index was used to quantify general health status; scores
closer to zero reflect better health [21].
Three aspects of vision were evaluated: 1) visual acuity,
using the Snellen vision chart, 2) color blindness, using
Ishihara pseudochromatic color test [22], and 3) contrast
sensitivity. Previous studies have indicated that visual acu-
ity and contrast sensitivity, a robust indicator of func-
tional vision [23], are associated with an increased risk of
falls among the elderly [16,24-26]. Visual acuity scores
were stratified in normal (i.e., good or mild decline, 6/6–
6/12) and abnormal (>6/15). Contrast sensitivity was
measured using a wall mounted clinical chart, a standard
clinical tool (Vistech VCTS 6000). The chart contains 5
rows of 9 printed circular patches each of which displays
a sine wave grating. There are 5 spatial frequencies across
the 5 rows (1.5, 3, 6, 12, and 18 cycles per degree). The
chart luminance was standardized according to the light
meter supplied with the chart. The last patch on which the
patient correctly identified the direction of the gratings
was recorded for each frequency. For all tests, each eye was
examined separately. The function of the better eye was
used in all analysis, since both eyes were used during
walking. The eye examinations were performed by a
neuro-ophthalmologist who was blinded to the gait meas-
ures in a subset of subjects who were selected at random.
Walking Protocol
Subjects were instructed to walk on level ground under
usual lighting conditions (1000 lumens) and in near
darkness (5 lumens). Although there are advantages to
performing these tests in a random order, the usual light-
ing condition was always performed first. If anything, this
should maximize safety and minimize the effects of the
walking in darkness; since this condition is always per-
formed second, subjects have more time to adapt to the
environment and walking conditions. Between the two
walks, subjects sat and rested for at least two minutes. In
order to control the lighting conditions, testing took place
in a large, quiet, empty room. The straight walking path
was 9 meters long. Subjects walked along the path six
times and were told to turn around and continue walking
when they reached the end of the path. All subjects were
tested in the same environment. Subjects were "guarded"
by a research assistant who walked a few steps away from
the subject, making sure not to interfere or set the pace.
Study subjects were not aware of the specific questions of
this investigation.
Assessment of Gait Dynamics
Previously described methods were used to quantify gait
variability and evaluate gait dynamics of each walk
[9,27,28]. Briefly, to measure the gait rhythm and the tim-
ing of the gait cycle (i.e., the stride time and the swing
time), a computerized force-sensitive system was used to
evaluate gait and stride-to-stride variability [29,30]. The
system measures the forces underneath the foot as a func-
tion of time. The system consists of a pair of shoes and a
recording unit. Each shoe contains 8 load sensors that
cover the surface of the sole and measure the vertical
forces under the foot. The recording unit (19 × 14 × 4.5
cm; 1.5 kg) is carried on the waist. Plantar pressures under
each foot are recorded at a rate of 100 Hz. Measurements
are stored in a memory card during the walk and, after the
walk, are transferred to a personal computer for further
analysis. Subsequently, the digitized data were transferred
to a computer workstation for analysis using software that
extracts the initial and end contact time of each stride and
determines stride and swing times. To focus on the assess-
ment of the dynamics of continuous, "normal" walking
and each subject's "intrinsic" dynamics and to ensure that
the analysis was not influenced by atypical strides (e.g.,
the turning at the end of the room), a median filter was
Table 1: Subjects characteristics*
Patients with HLGD (n = 22) Controls (n = 20)
Age (yrs) 80.7 ± 4.1 80.6 ± 6.3
Gender (% male) 73% 65%
Body-mass-index (kg/m2) 26.6 ± 4.9 25.1 ± 2.9
Mini Mental State Exam (MMSE) 28.1 ± 1.3 29.4 ± 0.9
Geriatric Depression Scale 5.6 ± 4.7 3.8 ± 2.6
Charlson Comorbidity Score 0.0 ± 0.0 0.5 ± 0.7
*Subject characteristics were not different in the two groups (p > 0.13), except that the MMSE and the Charlson score tended to be slightly 
different in the patients (p < 0.01). Values are mean ± SD or %, as indicated. HLGD: Higher-level gait disorder.Journal of NeuroEngineering and Rehabilitation 2005, 2:27 http://www.jneuroengrehab.com/content/2/1/27
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applied to each subject's time series to remove data points
that were three standard deviations greater than or less
than the median value [31]. Subsequently, the average
stride time, average swing time, stride time variability, and
swing time variability were determined. Variability was
calculated using the coefficient of variation (CV) of each
subject's stride time or swing time, e.g., (100 × standard
deviation of stride time)/(mean stride time). Stride-to-
stride variability reflects gait unsteadiness and arrhyth-
micity and has been shown to prospectively predict falls
[31-34]. The time to walk the 54 meters, the walk time,
was also measured. The values for the left and right feet
were highly correlated; for brevity, we report values from
only right foot.
Statistical Analysis
Descriptive statistics are reported as mean ± SD or %. We
used the Student's t and Chi-square tests to compare the
patient and control subjects with respect to different back-
ground characteristics (e.g., age, gender, vision) and
Spearman's correlation coefficient to quantify correlations
among measures. To evaluate the effect of lighting on gait
parameters and to compare the groups, we used Mixed
Effects Models for repeated measures. For each gait
parameter, a separate model was applied. The dependent
variable was the gait parameter and the independent vari-
ables were the group (patients or controls), the walking
condition (i.e., light or near darkness), and the interaction
term group × lighting condition. A p-value ≤ 0.05 (two-
sided) was considered statistically significant. All statisti-
cal analyses were performed using SPSS 11.5 and SAS 8.2
(Proc Mixed).
Results
Table 1 summarizes the general characteristics of the two
study groups. Patients and controls were similar with
respect to age, gender, body-mass-index, and depressive
symptoms. MMSE scores were slightly, but significantly
lower in the patients, but all subjects from both groups
scored a 26 or higher (i.e., they were non-demented).
Charlson scores were higher in the patients, but the scores
were generally low and close to 0 (low co-morbidity) in
both groups. As shown in Table 2, measures of visual acu-
ity, color blindness and contrast sensitivity were similar in
the patients and the controls.
Under normal lighting conditions, HLGD patients took
more time to complete the walk and walked with an
increased stride time, reduced swing time, and increased
stride-to-stride variability of the stride and swing time,
compared to the control subjects (p < 0.01) (see Table 3).
Compared to normal lighting conditions, both patients
and controls required significantly more time to complete
the walk when walking in near darkness (p < 0.005). Walk
times increased by 14.3% in the controls and by 15.8% in
the patients, in other words, by similar amounts (p =
0.828). Among the control subjects, walking in near dark-
ness did not significantly affect the average stride time, the
average swing time, or the stride-to-stride variability of
these measures (p > 0.29).
In contrast to the control group, the gait of the patients
with a HLGD became more abnormal when they walked
in near darkness. There was no change in the average
stride time when the patients walked in near darkness (p
= 0.376), but the average swing time significantly
decreased (p < 0.001), stride time variability increased (p
= 0.005) and swing time variability increased (p < 0.001).
As might be expected from Table 2, the group × lighting
condition interaction term was significant for the average
swing time (p = 0.015) and swing time variability (p =
0.005), indicating that near darkness affected the patients
more than the controls (see Figure 1), despite similar
increases in walk time. As noted above, all of the group
differences in gait observed during normal lighting condi-
tions persisted during walking in near darkness and the
gap between the two groups widened.
Among the background and vision measures evaluated
(e.g., age, gender, visual acuity, contrast sensitivity), the
MMSE and the Charlson scores were the only measures
that were significantly different and could, therefore,
potentially mediate the group-specific changes in gait dur-
ing walking in near dark. The MMSE was not correlated
Table 2: Measures of vision in the two study groups*
Patients with HLGD (n = 11) Controls (n = 15)
Visual Acuity (% normal) 82% 73%
Color Vision Test 8.2 ± 2.5 8.5 ± 1.3
Contrast Sensitivity Test: low spatial frequency 4.8 ± 0.7 4.5 ± 0.7
Contrast Sensitivity Test: intermediate spatial 
frequency
4.4 ± 0.7 4.2 ± 1.2
Contrast Sensitivity Test: high spatial frequency 1.8 ± 1.5 1.7 ± 1.5
*p > 0.19 for all comparisons.Journal of NeuroEngineering and Rehabilitation 2005, 2:27 http://www.jneuroengrehab.com/content/2/1/27
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with the change in any of the gait measures observed dur-
ing near dark walking (p > 0.17). Similarly, the Charlson
scores did not explain the change in any of the gait meas-
ures (p > 0.07).
Subjects who took longer to complete the walk with nor-
mal lighting generally showed a relative increase in the
walk time during near dark walking (r = 0.48; p = 0.001),
whereas the changes in stride time variability and swing
time variability were not significantly associated with the
baseline values of these measures (p > 0.17). The change
in stride time variability and swing time variability were
moderately correlated with each other (r = 0.38; p =
0.018). The change in swing time variability was moder-
ately correlated with the change in walk time (r = -0.40; p
= 0.016), but the change in stride time variability was not
correlated with the change in walk time (p = 0.12).
Discussion
To summarize, key findings of this study are: 1) Both
healthy older adults and older adults with a HLGD walk
more slowly under diminished lighting conditions; 2)
Diminished lighting does not increase the gait variability
of healthy older adults; and 3) In patients with a HLGD,
diminished lighting significantly increases gait variability.
In the following paragraphs, we attempt to interpret these
findings and discuss their implications for understanding
HLGD, the role of vision in gait, and the relationship
between visual impairment and increased fall risk in older
adults.
Perhaps the simplest way to interpret the slower walking
that occurs during diminished lighting conditions is that
subjects are adapting a more cautious gait in response to
the reduced lighting. This would be consistent with previ-
ous studies that suggest that gait slows down in the
absence of sufficient visual input [11-13], perhaps to
increase safety. This response of the healthy older adults
to walking in near darkness also parallels the effects of an
attention demanding task on the gait of healthy young
and older adults [35,36]. When healthy young or older
adults are asked to walk and perform an additional task
simultaneously, gait speed is reduced, but there is no
effect on gait variability [35,36]. From this perspective,
one could suggest that walking in near darkness requires
greater attention than walking under normal lighting.
When older adults with neurodegenerative disease or
those with an increased risk of falls walk while simultane-
ously performing an attention demanding task, two
things happen: 1) they slow down, like their healthy
peers, and 2) stride variability increases [28,35-37]. These
are the effects that were seen in the present study when the
patients with a HLGD walked in near darkness. As noted,
a possible explanation for this behavior, therefore, is that
for the patients with a HLGD, walking in the dark is an
attention demanding task. Alternatively, one could sug-
gest that walking in near darkness reduces self-efficacy of
walking in patients with HLGD, because they are already
predisposed to fear of falling, but not in the controls, who
do not have a marked concern about their gait. This could
explain the disparate response of the two groups. Indeed,
in older adults with a HLGD, fear of falling has been asso-
ciated with stride time variability [9]. However, if this
were the only contributing factor, one might have
expected to see a larger reduction in walk times in the
patient group, compared to the control, whereas the rela-
tive increases in walk times during near darkness were
similar in the two groups.
Another potential explanation for the increased stride var-
iability observed in the patients with a HLGD is based on
the relationship between gait speed, stride length and
stride frequency, on the one hand, and stride variability
on the other [38-40]. At least in certain populations, some
investigators suggest that variability of stride time and
stride length becomes greater at slower walking speeds.
One could argue that the increased variability observed in
the patients with a HLGD in near darkness is simply a
byproduct of their reduced walking speed. This
Table 3: Effects of lighting on gait
Patients with HLGD (n = 22) Controls (n = 20)
Normal Lighting Near Dark (P-value*) Normal Lighting Near Dark (P-value*)
Average Stride Time (sec) 1.30 ± 0.17 1.29 ± 0.15 (0.376) 1.17 ± 0.12 1.17 ± 0.12 (0.912)
Stride Time Variability (%) 5.6 ± 2.3 6.8 ± 2.3 (0.005) 3.6 ± 1.2 4.1 ± 1.9 (0.295)
Average Swing Time (%) 33.9 ± 2.7 32.5 ± 3.7 (<0.001) 35.7 ± 3.0 35.5 ± 3.2 (0.015)
Swing Time Variability (%) 7.0 ± 2.9 10.1 ± 4.7 (<0.001) 4.5 ± 2.4 5.1 ± 2.5 (0.365)
Walk Time (sec) 106.3 ± 44.2 124.4 ± 57.1 (<0.001) 72.8 ± 20.8 84.2 ± 33.5 (0.013)
*P-values shown in parentheses are based on within group comparisons between near dark and normal lighting. All measures of gait were different 
(p < 0.01) in the two subject groups, both under normal lighting and in near darkness. Walk time is the time to complete the 54 meter walk.Journal of NeuroEngineering and Rehabilitation 2005, 2:27 http://www.jneuroengrehab.com/content/2/1/27
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explanation is, however, likely to be incomplete or incor-
rect. First, as noted, the healthy controls slowed down
when walking in near darkness by virtually the same
extent as that seen in the patient group, yet variability
measures were unchanged in the controls. A reduced gait
speed by itself does not necessarily lead to increased vari-
ability (as is the case for the response of healthy subjects
to an attention demanding task, as discussed above). Sec-
ond, in a study of healthy older adults and patients with
Parkinson's disease, swing time variability was not
affected by gait speed, even when gait speed was reduced
by as much as 20% [30]. The increase in swing time vari-
ability observed among the patients with a HLGD during
walking in near darkness cannot, therefore, be attributed
to changes in gait speed.
Another way to view walking in near darkness is to con-
sider it not simply as a test of vision, but as a challenge to
other sensory feedback mechanisms that help to regulate
gait. Walking may normally rely on visual, vestibular and
proprioceptive feedback. When older adults or persons
with deficits in balance are asked to close their eyes while
standing on a balance platform, measures of sway and
postural instability increase, both compared to eyes open
conditions and compared to healthy young adults [41,
42]. These findings indicate that with aging, there is a
greater reliance on visual feedback for maintenance of
static balance; hence, when vision is removed, there is a
large decrement in postural stability. We can apply similar
reasoning to the present findings. In that case, one can
interpret the results to suggest that in the patients with a
HLGD, regulation of stride-to-stride variability relies on
visual input and other feedback mechanisms are unable
to fill in the gap that occurs when vision input is limited
in near dark walking. This would suggest that patients
with HLGD may have deficits in proprioception or vestib-
ular function. Such deficits have not been identified in the
present or previous studies of patients with HLGD [8,9]. It
is possible, however, that these changes are relatively sub-
tle and only surface when challenged.
The present study has several limitations. For example, we
did not directly examine the affect of lighting on stress or
fear of falling. Previous studies demonstrated that older
patients with a HLGD have deficits in frontal lobe func-
tion, impairment in tests of balance and gait, and an
increased risk of falls [8,9]. Future studies should assess if
and how these factors contributed to the observed effects
and how walking in darkness affects stress, anxiety and
confidence in walking. It would also be helpful to evalu-
ate other aspects of vision (e.g., peripheral vision) on a
larger sample. We were not able to identify the specific fac-
tor that explained the increased sensitivity of the gait of
patients with a HLGD to reduced lighting. Thus, the pre-
cise explanation for the further increase in stride-to-stride
variability in near darkness in the patients with a HLGD
remains to be determined.
Despite these limitations, the present findings shed light
on the link between visual impairment, gait disturbances,
and falls. Among older adults, falls are a major cause of
Effects of near darkness on stride time, stride time variability,  and swing time variability in the two groups Figure 1
Effects of near darkness on stride time, stride time variability, 
and swing time variability in the two groups. For both groups, 
the average stride time was not affected by the change in 
lighting (p > 0.37). During walking in near darkness, variability 
measures were not significantly changed in the healthy con-
trols (p > 0.29), but in the patients, stride time variability (p = 
0.005) and swing time variability (p < 0.001) became signifi-
cantly larger, compared to the values measured normal 
lighting.
1Journal of NeuroEngineering and Rehabilitation 2005, 2:27 http://www.jneuroengrehab.com/content/2/1/27
Page 7 of 8
(page number not for citation purposes)
morbidity and mortality [14]. Over one third of the adults
aged 65 and over fall at least once each year [14] and
among patients with a HLGD, falls are apparently much
more frequent [9]. Previous studies have demonstrated
that impaired vision is an important and independent risk
factor for falls [14-17,24-26]. The present findings suggest
a potential mechanism. With reduced vision or when
walking in near darkness, perhaps two sides of the same
coin, patients with an already increased risk of falls may
further predispose themselves to falls and instability by
increasing their stride-to-stride variability. A small pertur-
bation could then take an already unstable system and
cause a fall. Regardless of the precise explanation, the
present results highlight the inappropriate response of
patients with HLGD to reduced lighting conditions and
suggest how this situation may aggravate gait instability
and lead to falls in these older adults
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